Your browser doesn't support javascript.
loading
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.
Sheng, Wang-Huei; Chang, Sui-Yuan; Lin, Pin-Hung; Hsieh, Ming-Ju; Chang, Hao-Hsiang; Cheng, Chien-Yu; Yang, Hung-Chih; Pan, Ching-Fu; Ieong, Si-Man; Chao, Tai-Ling; Chen, Jang-Pin; Cheng, Shu-Hsing; Chang, Shan-Chwen.
  • Sheng WH; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei City, Taiwan.
  • Chang SY; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
  • Lin PH; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Hsieh MJ; Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Taiwan; Occupational Safety and Health Office, National Taiwan University Hospital, Taipei, Taiwan.
  • Chang HH; Department of Family Medicine, National Taiwan University Hospital and College of Medicine, Taipei 10016, Taiwan.
  • Cheng CY; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan; Institute of Public Health, School of Medicine National Yang-Ming Chiao Tung University, Taiwan.
  • Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Pan CF; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Ieong SM; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Chao TL; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Chen JP; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan; School of Clinical Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan.
  • Cheng SH; Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan; Institute of Public Health, School of Medicine National Yang-Ming Chiao Tung University, School of Public Health, Taipei Medical University, Taipei, Taiwan.
  • Chang SC; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei City, Taiwan. Electronic address: changsc@ntu.edu.tw.
J Formos Med Assoc ; 121(4): 766-777, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35305895
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Adult / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Adult / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article